An investigation of mammographic density and gene variants in healthy women

International Journal of Cancer

Volumn 112, Issue 4, 2004, Pages 683-688

  Maskarinec, Gertraud ^a   Lurie, Galina ^a   Williams, Andrew E ^a   Le Marchand, Loic ^a  

^a UNIVERSITY OF HAWAII CANCER CENTER   (United States)

Author keywords

Breast cancer; Gene variant; Mammographic density

Indexed keywords

CATECHOL METHYLTRANSFERASE; CYSTEINE; CYTOCHROME P450 17; CYTOCHROME P450 1A1; CYTOCHROME P450 1A2; CYTOCHROME P450 1B1; DNA; ENZYME; ISOLEUCINE; LEUCINE; METHIONINE; THREONINE; VALINE;

ADULT; ALLELE; AMINO ACID SUBSTITUTION; ARTICLE; ASIAN; BLOOD DONOR; BODY MASS; BREAST CANCER; CANCER RISK; CAUCASIAN; CONTROLLED STUDY; DENSITY; DNA DETERMINATION; DNA EXTRACTION; ENZYME ACTIVITY; ESTROGEN METABOLISM; ESTROGEN SYNTHESIS; ETHNOLOGY; FEMALE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MOUTHWASH; POLYMERASE CHAIN REACTION; PREMENOPAUSE; PRIORITY JOURNAL; REPRODUCTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; UNITED STATES;

ADULT; AGED; BODY MASS INDEX; BREAST NEOPLASMS; CATECHOL O-METHYLTRANSFERASE; CROSS-SECTIONAL STUDIES; CYTOCHROME P-450 CYP1A2; ETHNIC GROUPS; FEMALE; GENE DOSAGE; HUMANS; MAMMOGRAPHY; MIDDLE AGED; PREMENOPAUSE;

EID: 7044222934     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.20448     Document Type: Article

References (39)

1. Henderson BE, Pike MC, Bernstein L, Ross RK. Breast cancer. In: Schottenfeld D, ed. Cancer epidemiology and prevention. New York: Oxford University Press, 1996. 1022-39.
2. Toniolo PG, Levitz M, Zeleniuch-Jacquotte A, Banerjee S, Koenig KL, Shore RE, Strax P, Pasternack BS. A prospective study of endogenous estrogens and breast cancer in postmenopausal women. J Natl Cancer Inst 1995;87:190-7.
3. Hankinson SE, Willett WC, Manson JE, Colditz GA, Hunter DJ, Spiegelman D, Barbieri RL, Speizer FE. Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women. J Natl Cancer Inst 1998;90:1292-9.
4. Cauley JA, Lucas FL, Kuller LH, Stone K, Browner W, Cummings SR. Elevated serum estradiol and testosterone concentrations are associated with a high risk for breast cancer. Study of Osteoporotic Fractures Research Group. Ann Intern Med 1999;130:270-7.
5. Coughlin SS, Piper M. Genetic polymorphisms and risk of breast cancer. Cancer Epidemiol Biomarkers Prev 1999;8:1023-32.
6. Dunning AM, Healey CS, Pharoah PD, Teare MD, Ponder BA, Easton DF. A systematic review of genetic polymorphisms and breast cancer risk. Cancer Epidemiol Biomarkers Prev 1999;8:843-54.
7. Mitrunen K, Hirvonen A. Molecular epidemiology of sporadic breast cancer. The role of polymorphic genes involved in oestrogen biosynthesis and metabolism. Mutat Res 2003;544:9-41.
8. Brentano ST, Picado-Leonard J, Mellon SH, Moore CC, Miller WL. Tissue-specific, cyclic adenosine 3′,5′-monophosphate-induced, and phorbol ester-repressed transcription from the human P450c17 promoter in mouse cells. Mol Endocrinol 1990;4:1972-9.
9. Lee AJ, Cai MX, Thomas PE, Conney AH, Zhu BT. Characterization of the oxidative metabolites of 17beta-estradiol and estrone formed by 15 selectively expressed human cytochrome p450 isoforms. Endocrinology 2003;144:3382-98.
10. Zhu BT. Catechol-O-methyltransferase (COMT)-mediated methylation metabolism of endogenous bioactive catechols and modulation by endobiotics and xenobiotics: importance in pathophysiology and pathogenesis. Curr Drug Metab 2002;3:321-49.
11. Yager JD, Liehr JG. Molecular mechanisms of estrogen carcinogenesis. Annu Rev Pharmacol Toxicol 1996;36:203-32.
12. Thompson PA, Ambrosone C. Molecular epidemiology of genetic polymorphisms in estrogen metabolizing enzymes in human breast cancer. J Natl Cancer Inst Monogr 2000;125-34.
13. Boyd NF, Lockwood GA, Byng JW, Tritchler DL, Yaffe MJ. Mammographic densities and breast cancer risk. Cancer Epidemiol Biomarkers Prev 1998;7:1133-44.
14. Pankow JS, Vachon CM, Kuni CC, King RA, Arnett DK, Grabrick DM, Rich SS, Anderson VE, Sellers TA. Genetic analysis of mammographic breast density in adult women: evidence of a gene effect. J Natl Cancer Inst 1997;89:549-56.
15. Boyd NF, Dite GS, Stone J, Gunasekara A, English DR, McCredie MR, Giles GG, Tritchler D, Chiarelli A, Yaffe MJ, Hopper JL. Heritability of mammographic density, a risk factor for breast cancer. N Engl J Med 2002;347:886-94.
16. Greendale GA, Reboussin BA, Sie A, Singh HR, Olson LK, Gatewood O, Bassett LW, Wasilauskas C, Bush T, Barrett-Connor E. Effects of estrogen and estrogen-progestin on mammographic parenchymal density. Postmenopausal Estrogen/Progestin Interventions (PEPI) Investigators. Ann Intern Med 1999;130:262-9.
17. Greendale GA, Reboussin BA, Slone S, Wasilauskas C, Pike MC, Ursin G. Postmenopausal hormone therapy and change in mammographic density. J Natl Cancer Inst 2003;95:30-7.
18. Spicer DV, Ursin G, Parisky YR, Pearce JG, Shoupe D, Pike A, Pike MC. Changes in mammographic densities induced by a hormonal contraceptive designed to reduce breast cancer risk. J Natl Cancer Inst 1994;86:431-6.
19. Brisson J, Brisson B, Cote G, Maunsell E, Beruhe S, Robert J. Tamoxifen and mammographic breast densities. Cancer Epidemiol Biomarkers Prev 2000;9:911-5.
20. Boyd NF, Stone J, Martin LJ, Jong R, Fishell E, Yaffe M, Hammond G, Minkin S. The association of breast mitogens with mammographic densities. Br J Cancer 2002;87:876-82.
21. Haiman CA, Bernstein L, Berg D, Ingles SA, Salane M, Ursin G. Genetic determinants of mammographic density. Breast Cancer Res 2002;4:R5.
22. Haiman CA, Hankinson SE, DeVivo I, I, Guillemette C, Ishibe N, Hunter DJ, Byrne C. Polymorphisms in steroid hormone pathway genes and mammographic density. Breast Cancer Res Treat 2003;77:27-36.
23. 158Met polymorphism in catechol-O-methyltransferase gene associated with risk factors for breast cancer. Cancer Epidemiol Biomarkers Prev 2003;12:838-47.
24. Maskarinec G, Meng L, Ursin G. Ethnic differences in mammographic densities. Int J Epidemiol 2001;30:959-65.
25. Maskarinec G, Williams AE, Stanczyk FZ, Stanczyk FZ, Franke AA. A randomized isoflavone intervention among premenopausal women. Cancer Epidemiol Biomarkers Prev 2002;11:195-201.
26. Maskarinec G, Robbins C, Riola B, Kane-Sample L, Franke A, Murphy S. Three measures show high compliance in soy intervention among premenopausal women. J Am Diet Assoc 2003;103:861-6.
27. Stram DO, Hankin JH, Wilkens LR, Henderson B, Kolonel LN. Calibration of the dietary questionnaire for a multiethnic cohort in Hawaii and Los Angeles. Am J Epidemiol 2000;151:358-70.
28. Lavigne JA, Helzlsouer KJ, Huang HY, Strickland PT, Bell DA, Selmin O, Watson MA, Hoffman S, Comstock GW, Yager JD. An association between the allele coding for a low activity variant of catechol-O-methyltransferase and the risk for breast cancer. Cancer Res 1997;57:5493-7.
29. Le Marchand L, Sivaraman L, Pierce L, Seifried A, Lum A, Wilkens LR, Lau AF. Associations of CYP1A1, GSTM1, and CYP2E1 polymorphisms with lung cancer suggest cell type specificities to tobacco carcinogens. Cancer Res 1998;58:4858-63.
30. Sachse C, Brockmoller J, Bauer S, Roots I. Functional significance of a C→A polymorphism in intron 1 of the cytochrome P450 CYP1A2 gene tested with caffeine. Br J Clin Pharmacol 1999;47:445-9.
31. Bailey LR, Roodi N, Dupont WD, Pari FF. Association of cytochrome P450 1B1 (CYP1B1) polymorphism with steroid receptor status in breast cancer. Cancer Res 1998;58:5038-41.
32. Feigelson HS, Coetzee GA, Kolonel LN, Ross RK, Henderson BE. A polymorphism in the CYP17 gene increases the risk of breast cancer. Cancer Res 1997;57:1063-5.
33. Byng JW, Boyd NF, Fishell E, Jong RA, Yaffe MJ. The quantitative analysis of mammographic densities. Phys Med Biol 1994;39:1629-38.
34. Shrout P, Fleiss J. Intraclass correlations: uses in assessing rater reliability. Psychol Bull 1979;86:420-8.
35. SAS OnlineDoc, version 8. Cary, NC: SAS Institute, 2002. http://v8doc.sas.com/sashtml/.
36. Goodman MT, McDuffie K, Kolonel LN, Terada K, Donlon TA, Wilkens LR, Guo C, Le Marchand L. Case-control study of ovarian cancer and polymorphisms in genes involved in catecholestrogen formation and metabolism. Cancer Epidemiol Biomarkers Prev 2001;10:209-16.
37. Le Marchand L, Donlon T, Seifried A, Wilkens LR. Red meat intake, CYP2E1 genetic polymorphisms, and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 2002;11:1019-24.
38. Hirschhorn JN, Pearce CL, Altschuler D. Genomic approaches to the genetics of hormone-responsive cancer. In: Henderson BE, Ponder B, Ross RK, eds. Hormones, genes, and cancer. New York: Oxford University Press, 2003. 99-119.
39. Feigelson HS, Henderson BE. Future possibilities in the prevention of breast cancer: role of genetic variation in breast cancer prevention. Breast Cancer Res 2000;2:277-82.